You have read all your free articles, to continue reading subscribe to read the rest of this content.
The US Patent and Trademark Office (USPTO) and the Japanese Patent Office have informed Diamyd Medical that they will grant the patent for the company’s oral formulation of the GABA-based study drug Remygen. Remygen is currently in Phase 2 development through the ReGenerate-1 trial in individuaAlready a subscriber Login You…
AroCell has announced that the patent regarding the method of determining a likelihood of cancer relapse is now granted by United States Patent and Trademark Office. The patent claims the method of determining a likelihood of cancer relapse in a subject who has completed cancer tumour surgery, raAlready a subscriber…
Swedish biotech company Salipro Biotech has announced that the European Patent Office has issued the European Patent titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMXTM)Already a subscriber Login You have read all your free articles,…
The European Patent Office has granted a further European patent to the company, entitled “Antigen and method for production thereof”. The granted European patent follows the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. “We’re excited aAlready a subscriber Login You have…
